E S Eshak1, A E Arafa2. 1. Department of Public Health and Preventive Medicine, Faculty of Medicine, Minia University, Minia, 61511, Egypt; Public Health, Department of Social Medicine, Osaka University, Graduate School of Medicine, Suita Shi, 565-0871, Osaka, Japan. Electronic address: ehab@pbhel.med.osaka-u.ac.jp. 2. Department of Public Health, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Abstract
BACKGROUND AND AIM: Thiamine, also known as vitamin B1, functions as a cofactor in the metabolism of carbohydrates and amino acids. Thiamine deficiency has been suggested to be associated with many cardiovascular diseases (CVDs) and risk factors including type 1 and type 2 diabetes (T1D and T2D, respectively), obesity, chronic vascular inflammation, dyslipidemia, heart failure (HF), myocardial infarction (MI) and conduction defects, and depression. The aim of this review was to explore the evidence of thiamine deficiency among subjects with CVDs or risk factors, illustrate the theories explaining the thiamine-CVDs associations, and describe the effect of thiamine supplementation. METHODS: Human and animal studies were collected from various scientific databases following the PRISMA guidelines without limitation regarding the publication year. Studies investigating the prevalence of thiamine deficiency among patients with CVDs and the effect of thiamine supplementation on their conditions were summarized. RESULTS AND CONCLUSIONS: Thiamine deficiency could have a role in the development of CVDs. Future studies should focus on the impact of thiamine supplementation on reversing CVDs and risk factors associated with its deficiency.
BACKGROUND AND AIM: Thiamine, also known as vitamin B1, functions as a cofactor in the metabolism of carbohydrates and amino acids. Thiamine deficiency has been suggested to be associated with many cardiovascular diseases (CVDs) and risk factors including type 1 and type 2 diabetes (T1D and T2D, respectively), obesity, chronic vascular inflammation, dyslipidemia, heart failure (HF), myocardial infarction (MI) and conduction defects, and depression. The aim of this review was to explore the evidence of thiamine deficiency among subjects with CVDs or risk factors, illustrate the theories explaining the thiamine-CVDs associations, and describe the effect of thiamine supplementation. METHODS:Human and animal studies were collected from various scientific databases following the PRISMA guidelines without limitation regarding the publication year. Studies investigating the prevalence of thiamine deficiency among patients with CVDs and the effect of thiamine supplementation on their conditions were summarized. RESULTS AND CONCLUSIONS:Thiamine deficiency could have a role in the development of CVDs. Future studies should focus on the impact of thiamine supplementation on reversing CVDs and risk factors associated with its deficiency.
Authors: Mugagga Kalyesubula; Ramgopal Mopuri; Jimmy Asiku; Alexander Rosov; Sara Yosefi; Nir Edery; Samuel Bocobza; Uzi Moallem; Hay Dvir Journal: Dis Model Mech Date: 2021-03-18 Impact factor: 5.758